Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Documentation of torture and cruel, inhuman or degrading treatment of children: A review of existing guidelines and tools.

den Otter JJ, Smit Y, dela Cruz LB, Ozkalipci O, Oral R.

Forensic Sci Int. 2013 Jan 10;224(1-3):27-32. doi: 10.1016/j.forsciint.2012.11.003. Epub 2012 Nov 29. Review.

PMID:
23199437
2.

Access to health care for undocumented migrants: a comparative policy analysis of England and the Netherlands.

Grit K, den Otter JJ, Spreij A.

J Health Polit Policy Law. 2012 Feb;37(1):37-67. doi: 10.1215/03616878-1496011. Epub 2011 Oct 14.

PMID:
22003101
3.

Right to health care for vulnerable migrants.

den Otter JJ, Tavenier D.

Lancet. 2007 Sep 8;370(9590):828. No abstract available.

PMID:
17826168
4.

Early intervention with inhaled corticosteroids in subjects with rapid decline in lung function and signs of bronchial hyperresponsiveness: results from the DIMCA programme.

den Otter JJ, van Schayck CP, Folgering HT, van den Boom G, Akkermans RP, van Weel C.

Eur J Gen Pract. 2007;13(2):89-91.

PMID:
17534745
5.

Willingness of patients to perform self-management of asthma and the role of inhaled steroids.

Thoonen BP, Schermer TR, Akkermans RP, den Otter JJ, Grol R, van Schayck OC.

Scand J Prim Health Care. 2002 Mar;20(1):60-4.

PMID:
12086288
6.

Lung function measurement in general practice. General practice measurements compared with laboratory measurements during the DIMCA trial.

den Otter JJ, de Bruyn-Schmidt MA, Wolters MJ, van Schayck CP, Folgering HT, van Den Hoogen HJ, van Weel C.

Fam Pract. 2000 Aug;17(4):314-6.

PMID:
10934179
7.

Active detection of chronic obstructive pulmonary disease and asthma in the general population. Results and economic consequences of the DIMCA program.

van den Boom G, van Schayck CP, van Möllen MP, Tirimanna PR, den Otter JJ, van Grunsven PM, Buitendijk MJ, van Herwaarden CL, van Weel C.

Am J Respir Crit Care Med. 1998 Dec;158(6):1730-8.

PMID:
9847260
8.

How to avoid underdiagnosed asthma/chronic obstructive pulmonary disease?

den Otter JJ, van Dijk B, van Schayck CP, Molema J, van Weel C.

J Asthma. 1998;35(4):381-7.

PMID:
9669833
9.

Testing bronchial hyper-responsiveness: provocation or peak expiratory flow variability?

den Otter JJ, Reijnen GM, van den Bosch WJ, van Schayck CP, Molema J, van Weel C.

Br J Gen Pract. 1997 Aug;47(421):487-92.

10.

Spirometry in general practice: the performance of practice assistants scored by lung function technicians.

den Otter JJ, Knitel M, Akkermans RP, van Schayck CP, Folgering HT, van Weel C.

Br J Gen Pract. 1997 Jan;47(414):41-2.

11.

Prevalence of asthma and COPD in general practice in 1992: has it changed since 1977?

Tirimanna PR, van Schayck CP, den Otter JJ, van Weel C, van Herwaarden CL, van den Boom G, van Grunsven PM, van den Bosch WJ.

Br J Gen Pract. 1996 May;46(406):277-81.

12.

Evaluation of the suitability of weekly peak expiratory flow rate measurements in monitoring annual decline in lung function among patients with asthma and chronic bronchitis.

Tirimanna PR, Den Otter JJ, Van Schayck CP, Van Herwaarden CL, Folgering H, Van Weel C.

Br J Gen Pract. 1996 Jan;46(402):15-8.

13.

Periodic treatment regimens with inhaled steroids in asthma or chronic obstructive pulmonary disease. Is it possible?

van Schayck CP, van den Broek PJ, den Otter JJ, van Herwaarden CL, Molema J, van Weel C.

JAMA. 1995 Jul 12;274(2):161-4.

PMID:
7596005
14.

Does the continuous use of bronchodilators mask the progression of asthma or chronic bronchitis?

van Schayck CP, Folgering H, den Otter JJ, Tirimanna P, van Weel C.

Fam Pract. 1992 Dec;9(4):397-404.

PMID:
1490530

Supplemental Content

Loading ...
Support Center